Kiora Pharmaceuticals(KPRX.US)

Last Updated 19:00:00 ET
longbridge loading

Kiora Pharmaceuticals Inc 1Q 2026: Revenue ($2.4M), Net income ($2.42M), EPS ($0.58) — 10-Q Summary

TradingView·
US
KPRX
+3.97%
US
FBT
+1.54%
US
ARKG
+4.34%
TradingView·
US
KPRX
+3.97%
US
FBT
+1.54%
US
ARKG
+4.34%

Kiora Pharmaceuticals | 8-K: FY2026 Q1 Revenue: USD 0

Earnings Watch·
US
KPRX
+3.97%
Earnings Watch·
US
KPRX
+3.97%

Kiora Pharmaceuticals | 10-Q: FY2026 Q1 Revenue: USD 0

Earnings Watch·
US
KPRX
+3.97%
Earnings Watch·
US
KPRX
+3.97%

Kiora Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update | KPRX Stock News

StockTitan·
US
KPRX
+3.97%
US
IBB
+2.01%
US
PBE
+1.16%
StockTitan·
US
KPRX
+3.97%
US
IBB
+2.01%
US
PBE
+1.16%

12 Health Care Stocks Moving In Monday's After-Market Session

benzinga_article·
US
SANA
+1.96%
US
KPRX
+3.97%
US
CUE
+1.28%
benzinga_article·
US
SANA
+1.96%
US
KPRX
+3.97%
US
CUE
+1.28%

12 Health Care Stocks Moving In Wednesday's Intraday Session

benzinga_article·
US
IBB
+2.01%
US
ARKG
+4.34%
US
QNCX
+0.47%
benzinga_article·
US
IBB
+2.01%
US
ARKG
+4.34%
US
QNCX
+0.47%

U.S. stock market midday update: Kiora Pharmaceuticals financing news sparks market enthusiasm, stock price surges 19.76%!

Price Alert·
US
KPRX
+3.97%
Price Alert·
US
KPRX
+3.97%

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

benzinga_article·
US
PFSA
+0.40%
US
KPRX
+3.97%
US
CUPR
-1.86%
benzinga_article·
US
PFSA
+0.40%
US
KPRX
+3.97%
US
CUPR
-1.86%

Kiora Pharmaceuticals shares are trading higher after the company announced it will sell up to 438,471 shares in a private placement.

benzinga_article·
US
KPRX
+3.97%
US
LABU
+11.61%
US
BBH
+0.52%
benzinga_article·
US
KPRX
+3.97%
US
LABU
+11.61%
US
BBH
+0.52%

Kiora Pharmaceuticals Announces $5 Million Private Placement Financing

Tip Ranks·
US
FBT
+1.54%
US
LABU
+11.61%
US
BBH
+0.52%
Tip Ranks·
US
FBT
+1.54%
US
LABU
+11.61%
US
BBH
+0.52%
© 2026 Longbridge｜Disclaimer